Skip to main content
NCBI home page
Medline Book to support NIHPA logoLink to Medline Book to support NIHPA
. 2020 Jun;24(28):1–232. doi: 10.3310/hta24280

Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.

Kirsty Winkley, Rebecca Upsher, Daniel Stahl, Daniel Pollard, Architaa Kasera, Alan Brennan, Simon Heller, Khalida Ismail
PMCID: PMC7336224  PMID: 32568666

Abstract

BACKGROUND

For people with diabetes mellitus to achieve optimal glycaemic control, motivation to perform self-management is important. The research team wanted to determine whether or not psychological interventions are clinically effective and cost-effective in increasing self-management and improving glycaemic control.

OBJECTIVES

The first objective was to determine the clinical effectiveness of psychological interventions for people with type 1 diabetes mellitus and people with type 2 diabetes mellitus so that they have improved (1) glycated haemoglobin levels, (2) diabetes self-management and (3) quality of life, and fewer depressive symptoms. The second objective was to determine the cost-effectiveness of psychological interventions.

DATA SOURCES

The following databases were accessed (searches took place between 2003 and 2016): MEDLINE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Library, PsycINFO, EMBASE, Cochrane Controlled Trials Register, Web of Science, and Dissertation Abstracts International. Diabetes conference abstracts, reference lists of included studies and Clinicaltrials.gov trial registry were also searched.

REVIEW METHODS

Systematic review, aggregate meta-analysis, network meta-analysis, individual patient data meta-analysis and cost-effectiveness modelling were all used. Risk of bias of randomised and non-randomised controlled trials was assessed using the Cochrane Handbook (Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928).

DESIGN

Systematic review, meta-analysis, cost-effectiveness analysis and patient and public consultation were all used.

SETTING

Settings in primary or secondary care were included.

PARTICIPANTS

Adolescents and children with type 1 diabetes mellitus and adults with types 1 and 2 diabetes mellitus were included.

INTERVENTIONS

The interventions used were psychological treatments, including and not restricted to cognitive-behavioural therapy, counselling, family therapy and psychotherapy.

MAIN OUTCOME MEASURES

Glycated haemoglobin levels, self-management behaviours, body mass index, blood pressure levels, depressive symptoms and quality of life were all used as outcome measures.

RESULTS

A total of 96 studies were included in the systematic review (n = 18,659 participants). In random-effects meta-analysis, data on glycated haemoglobin levels were available for seven studies conducted in adults with type 1 diabetes mellitus (n = 851 participants) that demonstrated a pooled mean difference of -0.13 (95% confidence interval -0.33 to 0.07), a non-significant decrease in favour of psychological treatment; 18 studies conducted in adolescents/children with type 1 diabetes mellitus (n = 2583 participants) that demonstrated a pooled mean difference of 0.00 (95% confidence interval -0.18 to 0.18), indicating no change; and 49 studies conducted in adults with type 2 diabetes mellitus (n = 12,009 participants) that demonstrated a pooled mean difference of -0.21 (95% confidence interval -0.31 to -0.10), equivalent to reduction in glycated haemoglobin levels of -0.33% or ≈3.5 mmol/mol. For type 2 diabetes mellitus, there was evidence that psychological interventions improved dietary behaviour and quality of life but not blood pressure, body mass index or depressive symptoms. The results of the network meta-analysis, which considers direct and indirect effects of multiple treatment comparisons, suggest that, for adults with type 1 diabetes mellitus (7 studies; 968 participants), attention control and cognitive-behavioural therapy are clinically effective and cognitive-behavioural therapy is cost-effective. For adults with type 2 diabetes mellitus (49 studies; 12,409 participants), cognitive-behavioural therapy and counselling are effective and cognitive-behavioural therapy is potentially cost-effective. The results of the individual patient data meta-analysis for adolescents/children with type 1 diabetes mellitus (9 studies; 1392 participants) suggest that there were main effects for age and diabetes duration. For adults with type 2 diabetes mellitus (19 studies; 3639 participants), baseline glycated haemoglobin levels moderated treatment outcome.

LIMITATIONS

Aggregate meta-analysis was limited to glycaemic control for type 1 diabetes mellitus. It was not possible to model cost-effectiveness for adolescents/children with type 1 diabetes mellitus and modelling for type 2 diabetes mellitus involved substantial uncertainty. The individual patient data meta-analysis included only 40-50% of studies.

CONCLUSIONS

This review suggests that psychological treatments offer minimal clinical benefit in improving glycated haemoglobin levels for adults with type 2 diabetes mellitus. However, there was no evidence of benefit compared with control interventions in improving glycated haemoglobin levels for people with type 1 diabetes mellitus.

FUTURE WORK

Future work should consider the competency of the interventionists delivering a therapy and psychological approaches that are matched to a person and their life course.

STUDY REGISTRATION

This study is registered as PROSPERO CRD42016033619.

FUNDING

This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 28. See the NIHR Journals Library website for further project information.

Plain language summary

Living with diabetes mellitus (hereafter referred to as diabetes) involves taking on new roles and responsibilities and is key to success in achieving the best diabetes control. There are education programmes that help people with diabetes to access the information and skills needed but managing diabetes is hard and must be done 24/7, causing people to lose motivation. There are many emotional reasons for this. This research team aimed to discover if talking therapies that are designed to help people challenge their negative thoughts and feelings and be more motivated and confident could help improve their self-management and blood glucose levels. The team also wanted to find out if talking therapies could be good value for money and people with diabetes were asked for their views on the research. To conduct the research, electronic databases were searched for studies that have used talking therapies to support diabetes management. It was found that: For adults with type 2 diabetes, talking therapies improved diabetes control by only a small amount, although such therapies could represent value for money. People with type 2 diabetes who had talking therapy reported improved diet and quality of life. For adults with type 1 diabetes, some types of talking therapies could improve diabetes control, although this result was uncertain. Talking therapies were not effective for children or adolescents in improving diabetes control but there was not enough data to see if the therapies improved general health and well-being.When the results were presented to people with diabetes, they still wanted access to these treatments, even though results of this research did not suggest, overall, that talking therapies help improve diabetes control.Now that this research is complete, it is suggested that future studies look at whether or not more sessions of talking therapies should be delivered over a longer time period and whether or not the therapies should match the needs of the person with diabetes more closely.

Full text of this article can be found in Bookshelf.

References

  1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024 doi: 10.1016/j.diabres.2017.03.024. [DOI] [PubMed]
  2. World Health Organization. Global Report on Diabetes: Geneva: World Health Organization; 2016.
  3. Melmed S, Polonsky KS, Reed Larsen P, Kronenberg K. Williams Textbook of Endocrinology. 13th edn. Philadelphia, PA: Elsevier; 2016.
  4. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39:481–97. https://doi.org/10.1016/j.ecl.2010.05.011 doi: 10.1016/j.ecl.2010.05.011. [DOI] [PMC free article] [PubMed]
  5. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002;287:360–72. https://doi.org/10.1001/jama.287.3.360 doi: 10.1001/jama.287.3.360. [DOI] [PubMed]
  6. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Keaney JF Jr, Creager MA. Oral antioxidant therapy improves endothelial function in type 1 but not type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol 2003;285:H2392–H8. https://doi.org/10.1152/ajpheart.00403.2003 doi: 10.1152/ajpheart.00403.2003. [DOI] [PubMed]
  7. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53. https://doi.org/10.1016/S0140-6736(98)07019-6 doi: 10.1016/S0140-6736(98)07019-6. [DOI] [PubMed]
  8. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA 1996;276:1409–15. https://doi.org/10.1001/jama.276.17.1409 doi: 10.1001/jama.276.17.1409. [DOI] [PubMed]
  9. Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 2014;63:1738–47. https://doi.org/10.2337/db13-0468 doi: 10.2337/db13-0468. [DOI] [PubMed]
  10. Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008;358:2630–3. https://doi.org/10.1056/NEJMe0804182 doi: 10.1056/NEJMe0804182. [DOI] [PubMed]
  11. Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 2012;29:855–62. https://doi.org/10.1111/j.1464-5491.2012.03698.x doi: 10.1111/j.1464-5491.2012.03698.x. [DOI] [PubMed]
  12. Safford MM, Russell L, Suh DC, Roman S, Pogach L. How much time do patients with diabetes spend on self-care? J Am Board Fam Pract 2005;18:262–70. https://doi.org/10.3122/jabfm.18.4.262 doi: 10.3122/jabfm.18.4.262. [DOI] [PubMed]
  13. Khunti K, Gray LJ, Skinner T, Carey ME, Realf K, Dallosso H, et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ 2012;344:e2333. https://doi.org/10.1136/bmj.e2333 doi: 10.1136/bmj.e2333. [DOI] [PMC free article] [PubMed]
  14. Speight J, Amiel SA, Bradley C, Heller S, Oliver L, Roberts S, et al. Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled type 1 diabetes. Diabetes Res Clin Pract 2010;89:22–9. https://doi.org/10.1016/j.diabres.2010.03.017 doi: 10.1016/j.diabres.2010.03.017. [DOI] [PubMed]
  15. Gadsby R, Young B. Diabetes care in England and Wales: information from the 2010–2011 National Diabetes Audit. Diabet Med 2013;30:799–802. https://doi.org/10.1111/dme.12182 doi: 10.1111/dme.12182. [DOI] [PubMed]
  16. Winkley K, Stahl D, Chamley M, Stopford R, Boughdady M, Thomas S, et al. Low attendance at structured education for people with newly diagnosed type 2 diabetes: general practice characteristics and individual patient factors predict uptake. Patient Educ Couns 2016;99:101–7. https://doi.org/10.1016/j.pec.2015.08.015 doi: 10.1016/j.pec.2015.08.015. [DOI] [PubMed]
  17. Winkley K, Evwierhoma C, Amiel SA, Lempp HK, Ismail K, Forbes A. Patient explanations for non-attendance at structured diabetes education sessions for newly diagnosed type 2 diabetes: a qualitative study. Diabet Med 2015;32:120–8. https://doi.org/10.1111/dme.12556 doi: 10.1111/dme.12556. [DOI] [PubMed]
  18. Horigan G, Davies M, Findlay-White F, Chaney D, Coates V. Reasons why patients referred to diabetes education programmes choose not to attend: a systematic review. Diabet Med 2017;34:14–26. https://doi.org/10.1111/dme.13120 doi: 10.1111/dme.13120. [DOI] [PubMed]
  19. Harris S, Mulnier H, Amiel S. The barriers to uptake of diabetes education study. Lancet 2017;389:S44. https://doi.org/10.1016/S0140-6736(17)30440-3 doi: 10.1016/S0140-6736(17)30440-3. [DOI]
  20. Ryan RM, Deci EL. Intrinsic and extrinsic motivations: classic definitions and new directions. Contemp Educ Psychol 2000;25:54–67. https://doi.org/10.1006/ceps.1999.1020 doi: 10.1006/ceps.1999.1020. [DOI] [PubMed]
  21. Pettinati HM, Weiss RD, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. COMBINE Monograph Series, Volume 2. Medical Management Treatment Manual: A Clinical Research Guide for Medically Trained Clinicians Providing Pharmacotherapy as Part of the Treatment for Alcohol Dependence. US Department of Health and Human Services Publication No. (NIH) 04–5289. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2004.
  22. Becker MH. The health belief model and sick role behavior. Health Education Monographs 1974;2:409–19. https://doi.org/10.1177/109019817400200407 doi: 10.1177/109019817400200407. [DOI]
  23. Fishbein M, Ajzen I. Predicting and Changing Behavior: The Reasoned Action Approach. New York, NY: Taylor & Francis; 2010.
  24. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179–211. https://doi.org/10.1016/0749-5978(91)90020-T doi: 10.1016/0749-5978(91)90020-T. [DOI]
  25. Rogers RW. A protection motivation theory of fear appeals and attitude change1. J Psychol 1975;91:93–114. https://doi.org/10.1080/00223980.1975.9915803 doi: 10.1080/00223980.1975.9915803. [DOI] [PubMed]
  26. Rogers RW. Cognitive and Psychological Processes in Fear Appeals and Attitude Change: A Revised Theory of Protection Motivation. In Cacioppo JT, Petty RE, editors. Social Psychophysiology: A Sourcebook. New York, NY: Guildford Publications Inc.; 1983. pp. 153–76.
  27. National Institute for Health and Care Excellence (NICE). Type 1 Diabetes in Adults: Diagnosis and Management. NICE guideline NG17. London: NICE; 2016. URL: www.nice.org.uk/guidance/ng17 (accessed 21 September 2018).
  28. National Institute for Health and Care Excellence. Review of Clinical Guideline (CG66 and CG87 partial update) – Type 2 Diabetes: The Management of Type 2 Diabetes. NICE guideline CG87. London: NICE; 2009.
  29. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069–78. https://doi.org/10.2337/diacare.24.6.1069 doi: 10.2337/diacare.24.6.1069. [DOI] [PubMed]
  30. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851–8. https://doi.org/10.1016/S0140-6736(07)61415-9 doi: 10.1016/S0140-6736(07)61415-9. [DOI] [PubMed]
  31. Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res 2013;74:89–99. https://doi.org/10.1016/j.jpsychores.2012.11.013 doi: 10.1016/j.jpsychores.2012.11.013. [DOI] [PubMed]
  32. Ercan A, Kiziltan G. Obesity-related abnormal eating behaviors in type 2 diabetic patients. Pak J Med Sci 2013;29:1323–8. https://doi.org/10.12669/pjms.296.3657 doi: 10.12669/pjms.296.3657. [DOI] [PMC free article] [PubMed]
  33. Ahola AJ, Saraheimo M, Freese R, Mäkimattila S, Forsblom C, Groop PH, FinnDiane Study Group. Fear of hypoglycaemia and self-management in type 1 diabetes. J Clin Transl Endocrinol 2016;4:13–18. https://doi.org/10.1016/j.jcte.2016.02.002 doi: 10.1016/j.jcte.2016.02.002. [DOI] [PMC free article] [PubMed]
  34. Quandt SA, Reynolds T, Chapman C, Bell RA, Grzywacz JG, Ip EH, et al. Older adults’ fears about diabetes: using common sense models of disease to understand fear origins and implications for self-management. J Appl Gerontol 2013;32:783–803. https://doi.org/10.1177/0733464811435506 doi: 10.1177/0733464811435506. [DOI] [PMC free article] [PubMed]
  35. Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with type 1 or type 2 diabetes mellitus: a systematic review. Diabet Med 2013;30:512–24. https://doi.org/10.1111/dme.12128 doi: 10.1111/dme.12128. [DOI] [PubMed]
  36. Polonsky WH, Fisher L, Earles J, Dudl RJ, Lees J, Mullan J, Jackson RA. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care 2005;28:626–31. https://doi.org/10.2337/diacare.28.3.626 doi: 10.2337/diacare.28.3.626. [DOI] [PubMed]
  37. Polonsky WH. Diabetes Burnout: What To Do When You Can’t Take It Anymore. Arlington, VA: American Diabetes Association; 1999.
  38. van Bastelaar KM, Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AT, et al. Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in type 1 and type 2 diabetes. Diabet Med 2010;27:798–803. https://doi.org/10.1111/j.1464-5491.2010.03025.x doi: 10.1111/j.1464-5491.2010.03025.x. [DOI] [PubMed]
  39. Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, et al. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care 2007;30:542–8. https://doi.org/10.2337/dc06-1614 doi: 10.2337/dc06-1614. [DOI] [PubMed]
  40. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004;363:1589–97. https://doi.org/10.1016/S0140-6736(04)16202-8 doi: 10.1016/S0140-6736(04)16202-8. [DOI] [PubMed]
  41. Hodes M, Moorey S. Psychological Treatment in Disease and Illness. London: Gaskell Publications; 1993.
  42. Abraham C, Michie S. A taxonomy of behavior change techniques used in interventions. Health Psychol 2008;27:379–87. https://doi.org/10.1037/0278-6133.27.3.379 doi: 10.1037/0278-6133.27.3.379. [DOI] [PubMed]
  43. Hool N. BABCP Core Curriculum Reference Document. Bury: British Association for Behavioural & Cognitive Psychotherapies; 2010. URL: www.babcp.com/files/About/BABCP-Core-Curriculum-V2-190913.pdf (accessed 1 December 2017).
  44. Royal College of Psychiatrists. Psychotherapies. URL: www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/psychotherapies (accessed 1 December 2017).
  45. Candy J, Balfour FH, Cawley RH, Hildebrand HP, Malan DH, Marks IM, Wilson J. A feasibility study for a controlled trial of formal psychotherapy. Psychol Med 1972;2:345–62. https://doi.org/10.1017/S0033291700045165 doi: 10.1017/S0033291700045165. [DOI] [PubMed]
  46. Ciechanowski PS, Walker EA, Katon WJ, Russo JE. Attachment theory: a model for health care utilization and somatization. Psychosom Med 2002;64:660–7. https://doi.org/10.1097/00006842-200207000-00016 doi: 10.1097/00006842-200207000-00016. [DOI] [PubMed]
  47. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess 2001;5(35). https://doi.org/10.3310/hta5350 doi: 10.3310/hta5350. [DOI] [PubMed]
  48. Rogers C. Person-centred Therapy. In Nelson-Jones R, editor. Six Key Approaches to Counselling and Therapy. Thousand Oaks, CA: SAGE Publications Inc.; 2000. pp. 70–99.
  49. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003;71:843–61. https://doi.org/10.1037/0022-006X.71.5.843 doi: 10.1037/0022-006X.71.5.843. [DOI] [PubMed]
  50. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behaviour. 2nd edn. New York, NY: The Guildford Press; 2002. https://doi.org/10.1097/01445442-200305000-00013 doi: 10.1097/01445442-200305000-00013. [DOI]
  51. Rollnick S, Miller WR. What is motivational interviewing? Behav Cogn Psychother 1995;23:325–34. https://doi.org/10.1017/S135246580001643X doi: 10.1017/S135246580001643X. [DOI]
  52. Kellerman P. Participation’s perceptions of therapeutic factors in psychodrama. J Group Psychother Psychodrama Sociometry 1992;38:123–33.
  53. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES. Interpersonal Psychotherapy of Depression: A Brief, Focused, Specific Strategy. Lanham, MD: Jason Aronson, Incorporated; 1994.
  54. Carr A. The effectiveness of family therapy and systemic interventions for child-focused problems. J Fam Ther 2009;31:3–45. https://doi.org/10.1111/j.1467-6427.2008.00451.x doi: 10.1111/j.1467-6427.2008.00451.x. [DOI]
  55. Pennebaker JW, Seagal JD. Forming a story: the health benefits of narrative. J Clin Psychol 1999;55:1243–54. https://doi.org/10.1002/(SICI)1097-4679(199910)55:10<1243::AID-JCLP6>3.0.CO;2-N doi: 10.1002/(SICI)1097-4679(199910)55:10<1243::AID-JCLP6>3.0.CO;2-N. [DOI] [PubMed]
  56. Malchiodi CA. Understanding Children’s Drawings. New York, NY: Guilford Press; 1998.
  57. Winkley K, Ismail K, Landau S, Eisler I. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ 2006;333:65. https://doi.org/10.1136/bmj.38874.652569.55 doi: 10.1136/bmj.38874.652569.55. [DOI] [PMC free article] [PubMed]
  58. Baxter M, Hudson R, Mahon J, Bartlett C, Samyshkin Y, Alexiou D, Hex N. Estimating the impact of better management of glycaemic control in adults with type 1 and type 2 diabetes on the number of clinical complications and the associated financial benefit. Diabet Med 2016;33:1575–81. https://doi.org/10.1111/dme.13062 doi: 10.1111/dme.13062. [DOI] [PubMed]
  59. Li C, Xu D, Hu M, Tan Y, Zhang P, Li G, Chen L. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for patients with diabetes and depression. J Psychosom Res 2017;95:44–54. https://doi.org/10.1016/j.jpsychores.2017.02.006 doi: 10.1016/j.jpsychores.2017.02.006. [DOI] [PubMed]
  60. Wang ZD, Xia YF, Zhao Y, Chen LM. Cognitive behavioural therapy on improving the depression symptoms in patients with diabetes: a meta-analysis of randomized control trials. Biosci Rep 2017;37:BSR20160557. https://doi.org/10.1042/BSR20160557 doi: 10.1042/BSR20160557. [DOI] [PMC free article] [PubMed]
  61. Clery P, Stahl D, Ismail K, Treasure J, Kan C. Systematic review and meta-analysis of the efficacy of interventions for people with type 1 diabetes mellitus and disordered eating. Diabet Med 2017;34:1667–75. https://doi.org/10.1111/dme.13509 doi: 10.1111/dme.13509. [DOI] [PubMed]
  62. Ekong G, Kavookjian J. Motivational interviewing and outcomes in adults with type 2 diabetes: a systematic review. Patient Educ Couns 2016;99:944–52. https://doi.org/10.1016/j.pec.2015.11.022 doi: 10.1016/j.pec.2015.11.022. [DOI] [PubMed]
  63. Armour TA, Norris SL, Jack L, Zhang X, Fisher L. The effectiveness of family interventions in people with diabetes mellitus: a systematic review. Diabet Med 2005;22:1295–305. https://doi.org/10.1111/j.1464-5491.2005.01618.x doi: 10.1111/j.1464-5491.2005.01618.x. [DOI] [PubMed]
  64. Couch R, Jetha M, Dryden DM, Hooten N, Liang Y, Durec T, et al. Diabetes education for children with type 1 diabetes mellitus and their families. Evid Rep Technol Assess 2008;166:1–144. [PMC free article] [PubMed]
  65. Lawton J, Rankin D, Elliott J, Heller SR, Rogers HA, De Zoysa N, et al. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care 2014;37:109–15. https://doi.org/10.2337/dc13-1154 doi: 10.2337/dc13-1154. [DOI] [PubMed]
  66. Rondags SM, de Wit M, Snoek FJ. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia. Diabet Med 2016;33:184–91. https://doi.org/10.1111/dme.12876 doi: 10.1111/dme.12876. [DOI] [PubMed]
  67. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191–4. https://doi.org/10.1016/S0140-6736(00)04337-3 doi: 10.1016/S0140-6736(00)04337-3. [DOI] [PubMed]
  68. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9, W64. https://doi.org/10.7326/0003-4819-151-4-200908180-00135 doi: 10.7326/0003-4819-151-4-200908180-00135. [DOI] [PubMed]
  69. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 2000;23:943–50. https://doi.org/10.2337/diacare.23.7.943 doi: 10.2337/diacare.23.7.943. [DOI] [PubMed]
  70. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x doi: 10.1046/j.1525-1497.2001.016009606.x. [DOI] [PMC free article] [PubMed]
  71. Lewinsohn PM, Seeley JR, Roberts RE, Allen NB. Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging 1997;12:277–87. https://doi.org/10.1037/0882-7974.12.2.277 doi: 10.1037/0882-7974.12.2.277. [DOI] [PubMed]
  72. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9. https://doi.org/10.1192/bjp.134.4.382 doi: 10.1192/bjp.134.4.382. [DOI] [PubMed]
  73. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996. https://doi.org/10.1037/t00742-000 doi: 10.1037/t00742-000. [DOI]
  74. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed]
  75. Derrogatis L, Lipman R, Covi I. The SCL-90: an outpatient psychiatric rating scale. Psychopharmacology Bulletin 1973;9:13–28. [PubMed]
  76. Chopra P, Herrman H, Kennedy G. Comparison of disability and quality of life measures in patients with long-term psychotic disorders and patients with multiple sclerosis: an application of the WHO Disability Assessment Schedule II and WHO Quality of Life-BREF. Int J Rehabil Res 2008;31:141–9. https://doi.org/10.1097/MRR.0b013e32830150e6 doi: 10.1097/MRR.0b013e32830150e6. [DOI] [PubMed]
  77. Bott U, Mühlhauser I, Overmann H, Berger M. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998;21:757–69. https://doi.org/10.2337/diacare.21.5.757 doi: 10.2337/diacare.21.5.757. [DOI] [PubMed]
  78. Ferrans CE, Powers MJ. Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 1985;8:15–24. https://doi.org/10.1097/00012272-198510000-00005 doi: 10.1097/00012272-198510000-00005. [DOI] [PubMed]
  79. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33. https://doi.org/10.1097/00005650-199603000-00003 doi: 10.1097/00005650-199603000-00003. [DOI] [PubMed]
  80. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. https://doi.org/10.1136/bmj.d5928 doi: 10.1136/bmj.d5928. [DOI] [PMC free article] [PubMed]
  81. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-analysis. Chichester: John Wiley & Sons Ltd; 2011.
  82. Riley RD, Jackson D, Salanti G, Burke DL, Price M, Kirkham J, White IR. Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples. BMJ 2017;358:j3932. https://doi.org/10.1136/bmj.j3932 doi: 10.1136/bmj.j3932. [DOI] [PMC free article] [PubMed]
  83. Faltinsen EG, Storebø OJ, Jakobsen JC, Boesen K, Lange T, Gluud C. Network meta-analysis: the highest level of medical evidence? BMJ Evid Based Med 2018;23:56–9. https://doi.org/10.1136/bmjebm-2017-110887 doi: 10.1136/bmjebm-2017-110887. [DOI] [PubMed]
  84. White IR, Barrett JK, Jackson D, Higgins JP. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods 2012;3:111–25. https://doi.org/10.1002/jrsm.1045 doi: 10.1002/jrsm.1045. [DOI] [PMC free article] [PubMed]
  85. Higgins JP, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 2012;3:98–110. https://doi.org/10.1002/jrsm.1044 doi: 10.1002/jrsm.1044. [DOI] [PMC free article] [PubMed]
  86. White IR. Network meta-analysis. Stata J 2015;15:951–85. https://doi.org/10.1177/1536867X1501500403 doi: 10.1177/1536867X1501500403. [DOI]
  87. White IR, Thomas J. Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis. Clin Trials 2005;2:141–51. https://doi.org/10.1191/1740774505cn081oa doi: 10.1191/1740774505cn081oa. [DOI] [PubMed]
  88. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005;2:209–17. https://doi.org/10.1191/1740774505cn087oa doi: 10.1191/1740774505cn087oa. [DOI] [PubMed]
  89. Debray TP, Moons KG, van Valkenhoef G, Efthimiou O, Hummel N, Groenwold RH, Reitsma JB, GetReal Methods Review Group. Get real in individual participant data (IPD) meta-analysis: a review of the methodology. Res Synth Methods 2015;6:293–309. https://doi.org/10.1002/jrsm.1160 doi: 10.1002/jrsm.1160. [DOI] [PMC free article] [PubMed]
  90. Burke DL, Ensor J, Riley RD. Meta-analysis using individual participant data: one-stage and two-stage approaches, and why they may differ. Stat Med 2017;36:855–75. https://doi.org/10.1002/sim.7141 doi: 10.1002/sim.7141. [DOI] [PMC free article] [PubMed]
  91. Higgins JP, Whitehead A, Turner RM, Omar RZ, Thompson SG. Meta-analysis of continuous outcome data from individual patients. Stat Med 2001;20:2219–41. https://doi.org/10.1002/sim.918 doi: 10.1002/sim.918. [DOI] [PubMed]
  92. Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med 2000;19:3417–32. https://doi.org/10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L doi: 10.1002/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L. [DOI] [PubMed]
  93. Kontopantelis E, Reeves D. A short guide and a forest plot command (ipdforest) for one-stage meta-analysis. Stata J 2013;13:574–87. https://doi.org/10.1177/1536867X1301300308 doi: 10.1177/1536867X1301300308. [DOI]
  94. Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6:461–4. https://doi.org/10.1214/aos/1176344136 doi: 10.1214/aos/1176344136. [DOI]
  95. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455–63. https://doi.org/10.1111/j.0006-341X.2000.00455.x doi: 10.1111/j.0006-341X.2000.00455.x. [DOI] [PubMed]
  96. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924–6. https://doi.org/10.1136/bmj.39489.470347.AD doi: 10.1136/bmj.39489.470347.AD. [DOI] [PMC free article] [PubMed]
  97. Li M, Li T, Shi BY, Gao CX. Impact of motivational interviewing on the quality of life and its related factors in type 2 diabetes mellitus patients with poor long-term glycemic control. Int J Nurs Sci 2014;1:250–4. https://doi.org/10.1016/j.ijnss.2014.05.022 doi: 10.1016/j.ijnss.2014.05.022. [DOI]
  98. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919. https://doi.org/10.1136/bmj.i4919 doi: 10.1136/bmj.i4919. [DOI] [PMC free article] [PubMed]
  99. Breeze P, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, et al. SPHR Diabetes Prevention Model: Detailed Description of Model Background, Methods, Assumptions and Parameters. HEDS Discussion Paper Series (15.01). Sheffield: Health Economics and Decision Science, School of Health and Related Research (ScHARR), University of Sheffield; 2015.
  100. Mount Hood Diabetes Challenge Network. Diabetes Simulation Modeling Database. URL: www.mthooddiabeteschallenge.com/registry (accessed 1 July 2016).
  101. Patel A, Maissi E, Chang HC, Rodrigues I, Smith M, Thomas S, et al. Motivational enhancement therapy with and without cognitive behaviour therapy for type 1 diabetes: economic evaluation from a randomized controlled trial. Diabet Med 2011;28:470–9. https://doi.org/10.1111/j.1464-5491.2010.03198.x doi: 10.1111/j.1464-5491.2010.03198.x. [DOI] [PubMed]
  102. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Cost Eff Resour Alloc 2013;11:6. https://doi.org/10.1186/1478-7547-11-6 doi: 10.1186/1478-7547-11-6. [DOI] [PMC free article] [PubMed]
  103. Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, et al. Computer modeling of diabetes and its transparency: a report on the eighth Mount Hood challenge. Value Health 2018;21:724–31. https://doi.org/10.1016/j.jval.2018.02.002 doi: 10.1016/j.jval.2018.02.002. [DOI] [PMC free article] [PubMed]
  104. van Son J, Nyklíček I, Pop VJ, Blonk MC, Erdtsieck RJ, Pouwer F. Mindfulness-based cognitive therapy for people with diabetes and emotional problems: long-term follow-up findings from the DiaMind randomized controlled trial. J Psychosom Res 2014;77:81–4. https://doi.org/10.1016/j.jpsychores.2014.03.013 doi: 10.1016/j.jpsychores.2014.03.013. [DOI] [PubMed]
  105. Hermanns N, Schmitt A, Gahr A, Herder C, Nowotny B, Roden M, et al. The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care 2015;38:551–60. https://doi.org/10.2337/dc14-1416 doi: 10.2337/dc14-1416. [DOI] [PubMed]
  106. Petrak F, Herpertz S, Albus C, Hermanns N, Hiemke C, Hiller W, et al. Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the Diabetes and Depression (DAD) study: a randomized controlled multicenter trial. Diabetes Care 2015;38:767–75. https://doi.org/10.2337/dc14-1599 doi: 10.2337/dc14-1599. [DOI] [PubMed]
  107. Whittemore R, Melkus GD, Sullivan A, Grey M. A nurse-coaching intervention for women with type 2 diabetes. Diabetes Educ 2004;30:795–804. https://doi.org/10.1177/014572170403000515 doi: 10.1177/014572170403000515. [DOI] [PubMed]
  108. Williams A, Manias E, Walker R, Gorelik A. A multifactorial intervention to improve blood pressure control in co-existing diabetes and kidney disease: a feasibility randomized controlled trial. J Adv Nurs 2012;68:2515–25. https://doi.org/10.1111/j.1365-2648.2012.05950.x doi: 10.1111/j.1365-2648.2012.05950.x. [DOI] [PubMed]
  109. Siebolds M, Gaedeke O, Schwedes U, SMBG Study Group. Self-monitoring of blood glucose – psychological aspects relevant to changes in HbA1c in type 2 diabetic patients treated with diet or diet plus oral antidiabetic medication. Patient Educ Couns 2006;62:104–10. https://doi.org/10.1016/j.pec.2005.06.013 doi: 10.1016/j.pec.2005.06.013. [DOI] [PubMed]
  110. Keeratiyutawong P, Hanucharurnkul S, Melkus GDE, Panpakdee O, Vorapongsathorn T. Effectiveness of a self-management program for Thais with type 2 diabetes. Thai J Nurs Res 2006;10:85–97.
  111. Gregg JA, Callaghan GM, Hayes SC, Glenn-Lawson JL. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J Consult Clin Psychol 2007;75:336–43. https://doi.org/10.1037/0022-006X.75.2.336 doi: 10.1037/0022-006X.75.2.336. [DOI] [PubMed]
  112. West DS, DiLillo V, Bursac Z, Gore SA, Greene PG. Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care 2007;30:1081–7. https://doi.org/10.2337/dc06-1966 doi: 10.2337/dc06-1966. [DOI] [PubMed]
  113. Dale J, Caramlau I, Sturt J, Friede T, Walker R. Telephone peer-delivered intervention for diabetes motivation and support: the telecare exploratory RCT. Patient Educ Couns 2009;75:91–8. https://doi.org/10.1016/j.pec.2008.09.014 doi: 10.1016/j.pec.2008.09.014. [DOI] [PubMed]
  114. Davazdah Emamy MH, Roshan R, Mehrabi A, Attari A. The effectiveness of cognitive-behavioral stress management training on glycemic control and depression in patients with type 2 diabetes. [Persian]. Iran J Endocrinol Metab 2009;11:385–92.
  115. Sacco WP, Malone JI, Morrison AD, Friedman A, Wells K. Effect of a brief, regular telephone intervention by paraprofessionals for type 2 diabetes. J Behav Med 2009;32:349–59. https://doi.org/10.1007/s10865-009-9209-4 doi: 10.1007/s10865-009-9209-4. [DOI] [PubMed]
  116. Evans G, Lewin TJ, Bowen K, Lowe J. Dealing with anxiety: a pilot cognitive behavioural therapy program for diabetic clinic outpatient attendees. Int J Diabetes Mellit 2010;2:51–5. https://doi.org/10.1016/j.ijdm.2009.12.010 doi: 10.1016/j.ijdm.2009.12.010. [DOI]
  117. Wolever RQ, Dreusicke M, Fikkan J, Hawkins TV, Yeung S, Wakefield J, et al. Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial. Diabetes Educ 2010;36:629–39. https://doi.org/10.1177/0145721710371523 doi: 10.1177/0145721710371523. [DOI] [PubMed]
  118. D’Eramo Melkus G, Chyun D, Vorderstrasse A, Newlin K, Jefferson V, Langerman S. The effect of a diabetes education, coping skills training, and care intervention on physiological and psychosocial outcomes in black women with type 2 diabetes. Biol Res Nurs 2010;12:7–19. https://doi.org/10.1177/1099800410369825 doi: 10.1177/1099800410369825. [DOI] [PubMed]
  119. De Greef K, Deforche B, Tudor-Locke C, De Bourdeaudhuij I. A cognitive-behavioural pedometer-based group intervention on physical activity and sedentary behaviour in individuals with type 2 diabetes. Health Educ Res 2010;25:724–36. https://doi.org/10.1093/her/cyq017 doi: 10.1093/her/cyq017. [DOI] [PMC free article] [PubMed]
  120. Hawkins SY. Improving glycemic control in older adults using a videophone motivational diabetes self-management intervention. Res Theory Nurs Pract 2010;24:217–32. https://doi.org/10.1891/1541-6577.24.4.217 doi: 10.1891/1541-6577.24.4.217. [DOI] [PubMed]
  121. Osborn CY, Amico KR, Cruz N, O’Connell AA, Perez-Escamilla R, Kalichman SC, et al. A brief culturally tailored intervention for Puerto Ricans with type 2 diabetes. Health Educ Behav 2010;37:849–62. https://doi.org/10.1177/1090198110366004 doi: 10.1177/1090198110366004. [DOI] [PMC free article] [PubMed]
  122. García-Huidobro D, Bittner M, Brahm P, Puschel K. Family intervention to control type 2 diabetes: a controlled clinical trial. Fam Pract 2011;28:4–11. https://doi.org/10.1093/fampra/cmq069 doi: 10.1093/fampra/cmq069. [DOI] [PubMed]
  123. Keogh KM, Smith SM, White P, McGilloway S, Kelly A, Gibney J, O’Dowd T. Psychological family intervention for poorly controlled type 2 diabetes. Am J Manag Care 2011;17:105–13. [PubMed]
  124. De Greef K, Deforche B, Tudor-Locke C, De Bourdeaudhuij I. Increasing physical activity in Belgian type 2 diabetes patients: a three-arm randomized controlled trial. Int J Behav Med 2011;18:188–98. https://doi.org/10.1007/s12529-010-9124-7 doi: 10.1007/s12529-010-9124-7. [DOI] [PubMed]
  125. Hamid N. Effects of stress management training on glycemic control in women with type 2 diabetes. [Persian]. Iran J Endocrinol Metab 2011;13:346–53.
  126. Piette JD, Richardson C, Himle J, Duffy S, Torres T, Vogel M, et al. A randomized trial of telephonic counseling plus walking for depressed diabetes patients. Med Care 2011;49:641–8. https://doi.org/10.1097/MLR.0b013e318215d0c9 doi: 10.1097/MLR.0b013e318215d0c9. [DOI] [PMC free article] [PubMed]
  127. Lamers F, Jonkers CC, Bosma H, Knottnerus JA, van Eijk JT. Treating depression in diabetes patients: does a nurse-administered minimal psychological intervention affect diabetes-specific quality of life and glycaemic control? A randomized controlled trial. J Adv Nurs 2011;67:788–99. https://doi.org/10.1111/j.1365-2648.2010.05540.x doi: 10.1111/j.1365-2648.2010.05540.x. [DOI] [PubMed]
  128. Welch G, Zagarins SE, Feinberg RG, Garb JL. Motivational interviewing delivered by diabetes educators: does it improve blood glucose control among poorly controlled type 2 diabetes patients? Diabetes Res Clin Pract 2011;91:54–60. https://doi.org/10.1016/j.diabres.2010.09.036 doi: 10.1016/j.diabres.2010.09.036. [DOI] [PMC free article] [PubMed]
  129. Ell K, Katon W, Xie B, Lee PJ, Kapetanovic S, Guterman J, Chou CP. One-year postcollaborative depression care trial outcomes among predominantly Hispanic diabetes safety net patients. Gen Hosp Psychiatry 2011;33:436–42. https://doi.org/10.1016/j.genhosppsych.2011.05.018 doi: 10.1016/j.genhosppsych.2011.05.018. [DOI] [PMC free article] [PubMed]
  130. Farmer A, Hardeman W, Hughes D, Prevost AT, Kim Y, Craven A, et al. An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes. BMC Fam Pract 2012;13:30. https://doi.org/10.1186/1471-2296-13-30 doi: 10.1186/1471-2296-13-30. [DOI] [PMC free article] [PubMed]
  131. Penckofer SM, Ferrans C, Mumby P, Byrn M, Emanuele MA, Harrison PR, et al. A psychoeducational intervention (SWEEP) for depressed women with diabetes. Ann Behav Med 2012;44:192–206. https://doi.org/10.1007/s12160-012-9377-2 doi: 10.1007/s12160-012-9377-2. [DOI] [PMC free article] [PubMed]
  132. Hartmann M, Kopf S, Kircher C, Faude-Lang V, Djuric Z, Augstein F, et al. Sustained effects of a mindfulness-based stress-reduction intervention in type 2 diabetic patients: design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-study). Diabetes Care 2012;35:945–7. https://doi.org/10.2337/dc11-1343 doi: 10.2337/dc11-1343. [DOI] [PMC free article] [PubMed]
  133. Chen SM, Creedy D, Lin HS, Wollin J. Effects of motivational interviewing intervention on self-management, psychological and glycemic outcomes in type 2 diabetes: a randomized controlled trial. Int J Nurs Stud 2012;49:637–44. https://doi.org/10.1016/j.ijnurstu.2011.11.011 doi: 10.1016/j.ijnurstu.2011.11.011. [DOI] [PubMed]
  134. Plotnikoff RC, Karunamuni N, Courneya KS, Sigal RJ, Johnson JA, Johnson ST. The Alberta Diabetes and Physical Activity Trial (ADAPT): a randomized trial evaluating theory-based interventions to increase physical activity in adults with type 2 diabetes. Ann Behav Med 2013;45:45–56. https://doi.org/10.1007/s12160-012-9405-2 doi: 10.1007/s12160-012-9405-2. [DOI] [PubMed]
  135. Welschen LM, van Oppen P, Bot SD, Kostense PJ, Dekker JM, Nijpels G. Effects of a cognitive behavioural treatment in patients with type 2 diabetes when added to managed care; a randomised controlled trial. J Behav Med 2013;36:556–66. https://doi.org/10.1007/s10865-012-9451-z doi: 10.1007/s10865-012-9451-z. [DOI] [PubMed]
  136. Mandel SE, Davis BA, Secic M. Effects of music therapy and music-assisted relaxation and imagery on health-related outcomes in diabetes education: a feasibility study. Diabetes Educ 2013;39:568–81. https://doi.org/10.1177/0145721713492216 doi: 10.1177/0145721713492216. [DOI] [PubMed]
  137. Jansink R, Braspenning J, Keizer E, van der Weijden T, Elwyn G, Grol R. No identifiable Hb1Ac or lifestyle change after a comprehensive diabetes programme including motivational interviewing: a cluster randomised trial. Scand J Prim Health Care 2013;31:119–27. https://doi.org/10.3109/02813432.2013.797178 doi: 10.3109/02813432.2013.797178. [DOI] [PMC free article] [PubMed]
  138. Juul L, Maindal HT, Zoffmann V, Frydenberg M, Sandbaek A. Effectiveness of a training course for general practice nurses in motivation support in type 2 diabetes care: a cluster-randomised trial. PLOS ONE 2014;9:e96683. https://doi.org/10.1371/journal.pone.0096683 doi: 10.1371/journal.pone.0096683. [DOI] [PMC free article] [PubMed]
  139. Steed L, Barnard M, Hurel S, Jenkins C, Newman S. How does change occur following a theoretically based self-management intervention for type 2 diabetes. Psychol Health Med 2014;19:536–46. https://doi.org/10.1080/13548506.2013.845301 doi: 10.1080/13548506.2013.845301. [DOI] [PubMed]
  140. Safren SA, Gonzalez JS, Wexler DJ, Psaros C, Delahanty LM, Blashill AJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care 2014;37:625–33. https://doi.org/10.2337/dc13-0816 doi: 10.2337/dc13-0816. [DOI] [PMC free article] [PubMed]
  141. Gois C, Dias VV, Carmo I, Duarte R, Ferro A, Santos AL, et al. Treatment response in type 2 diabetes patients with major depression. Clin Psychol Psychother 2014;21:39–48. https://doi.org/10.1002/cpp.1817 doi: 10.1002/cpp.1817. [DOI] [PubMed]
  142. Griffin SJ, Simmons RK, Prevost AT, Williams KM, Hardeman W, Sutton S, et al. Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial. Diabetologia 2014;57:1308–19. https://doi.org/10.1007/s00125-014-3236-6 doi: 10.1007/s00125-014-3236-6. [DOI] [PMC free article] [PubMed]
  143. Eakin EG, Winkler EA, Dunstan DW, Healy GN, Owen N, Marshall AM, et al. Living well with diabetes: 24-month outcomes from a randomized trial of telephone-delivered weight loss and physical activity intervention to improve glycemic control. Diabetes Care 2014;37:2177–85. https://doi.org/10.2337/dc13-2427 doi: 10.2337/dc13-2427. [DOI] [PubMed]
  144. Kim MT, Kim KB, Huh B, Nguyen T, Han HR, Bone LR, Levine D. The effect of a community-based self-help intervention: Korean Americans with type 2 diabetes. Am J Prev Med 2015;49:726–37. https://doi.org/10.1016/j.amepre.2015.04.033 doi: 10.1016/j.amepre.2015.04.033. [DOI] [PMC free article] [PubMed]
  145. Chlebowy DO, El-Mallakh P, Myers J, Kubiak N, Cloud R, Wall MP. Motivational interviewing to improve diabetes outcomes in African Americans adults with diabetes. West J Nurs Res 2015;37:566–80. https://doi.org/10.1177/0193945914530522 doi: 10.1177/0193945914530522. [DOI] [PubMed]
  146. Pladevall M, Divine G, Wells KE, Resnicow K, Williams LK. A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control. Diabetes Educ 2015;41:136–46. https://doi.org/10.1177/0145721714561031 doi: 10.1177/0145721714561031. [DOI] [PMC free article] [PubMed]
  147. Pibernik-Okanović M, Hermanns N, Ajduković D, Kos J, Prašek M, Šekerija M, Lovrenčić MV. Does treatment of subsyndromal depression improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual. Trials 2015;16:305. https://doi.org/10.1186/s13063-015-0833-8 doi: 10.1186/s13063-015-0833-8. [DOI] [PMC free article] [PubMed]
  148. Huang CY, Lai HL, Chen CI, Lu YC, Li SC, Wang LW, Su Y. Effects of motivational enhancement therapy plus cognitive behaviour therapy on depressive symptoms and health-related quality of life in adults with type II diabetes mellitus: a randomised controlled trial. Qual Life Res 2016;25:1275–83. https://doi.org/10.1007/s11136-015-1165-6 doi: 10.1007/s11136-015-1165-6. [DOI] [PubMed]
  149. Browning C, Chapman A, Yang H, Liu S, Zhang T, Enticott JC, Thomas SA. Management of type 2 diabetes in China: the Happy Life Club, a pragmatic cluster randomised controlled trial using health coaches. BMJ Open 2016;6:e009319. https://doi.org/10.1136/bmjopen-2015-009319 doi: 10.1136/bmjopen-2015-009319. [DOI] [PMC free article] [PubMed]
  150. Kasteleyn MJ, Vos RC, Rijken M, Schellevis FG, Rutten GE. Effectiveness of tailored support for people with type 2 diabetes after a first acute coronary event: a multicentre randomized controlled trial (the Diacourse-ACE study). Diabet Med 2016;33:125–33. https://doi.org/10.1111/dme.12816 doi: 10.1111/dme.12816. [DOI] [PubMed]
  151. Chiu CJ, Hu YH, Wray LA, Beverley EA, Yang YC, Wu JS, Lu FH. Dissemination of evidence-base minimal psychological intervention for diabetes management in Taiwan adults with type 2 diabetes. Int J Clin Exp Med 2016;9:14489–98.
  152. Clark M, Hampson SE, Avery L, Simpson R. Effects of a tailored lifestyle self-management intervention in patients with type 2 diabetes. Br J Health Psychol 2004;9:365–79. https://doi.org/10.1348/1359107041557066 doi: 10.1348/1359107041557066. [DOI] [PubMed]
  153. Hokanson JM, Anderson RL, Hennrikus DJ, Lando HA, Kendall DM. Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. Diabetes Educ 2006;32:562–70. https://doi.org/10.1177/0145721706289914 doi: 10.1177/0145721706289914. [DOI] [PubMed]
  154. Heinrich E, Candel MJ, Schaper NC, de Vries NK. Effect evaluation of a Motivational Interviewing based counselling strategy in diabetes care. Diabetes Res Clin Pract 2010;90:270–8. https://doi.org/10.1016/j.diabres.2010.09.012 doi: 10.1016/j.diabres.2010.09.012. [DOI] [PubMed]
  155. Pourisharif H, Babapour J, Zamani R, Besharat MA, Mehryar AH, Rajab A. The effectiveness of motivational interviewing in improving health outcomes in adults with type 2 diabetes. Procedia Soc Behav Sci 2010;5:1580–4. https://doi.org/10.1016/j.sbspro.2010.07.328 doi: 10.1016/j.sbspro.2010.07.328. [DOI]
  156. Castelnuovo G, Manzoni GM, Cuzziol P, Cesa GL, Corti S, Tuzzi C, et al. TECNOB Study: ad interim results of a randomized controlled trial of a multidisciplinary telecare intervention for obese patients with type-2 diabetes. Clin Pract Epidemiol Ment Health 2011;7:44–50. https://doi.org/10.2174/1745017901107010044 doi: 10.2174/1745017901107010044. [DOI] [PMC free article] [PubMed]
  157. Waker CL. Effects of Motivational Interviewing on Diabetes Self-Management Behaviors and Glycemic Control in Type 2 Diabetes: A Translational Study. PhD thesis. Cincinnati, OH: University of Cincinnati; 2012.
  158. Gabbay RA, Añel-Tiangco RM, Dellasega C, Mauger DT, Adelman A, Van Horn DH. Diabetes nurse case management and motivational interviewing for change (DYNAMIC): results of a 2-year randomized controlled pragmatic trial. J Diabetes 2013;5:349–57. https://doi.org/10.1111/1753-0407.12030 doi: 10.1111/1753-0407.12030. [DOI] [PMC free article] [PubMed]
  159. Jiang FG, Dong ZQ, Li XR, Fu XQ, Zhang X, Zhang L, et al. Effects of paroxetine plus group psychotherapy in treatment of anxiety disorders accompanying impaired glucose regulation: a randomized double-blind controlled trial. Chinese Mental Health Journal 2014;28:321–6.
  160. Inouye J, Li D, Davis J, Arakaki R. Psychosocial and clinical outcomes of a cognitive behavioral therapy for Asians and Pacific Islanders with Type 2 diabetes: a randomized clinical trial. Hawaii J Med Public Health 2015;74:360–8. [PMC free article] [PubMed]
  161. Fitzpatrick SL, Golden SH, Stewart K, Sutherland J, DeGross S, Brown T, et al. Effect of DECIDE (Decision-making Education for Choices In Diabetes Everyday) program delivery modalities on clinical and behavioral outcomes in urban African Americans with type 2 diabetes: a randomized trial. Diabetes Care 2016;39:2149–57. https://doi.org/10.2337/dc16-0941 doi: 10.2337/dc16-0941. [DOI] [PMC free article] [PubMed]
  162. Amsberg S, Anderbro T, Wredling R, Lisspers J, Lins PE, Adamson U, Johansson UB. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients – a randomized controlled trial. Patient Educ Couns 2009;77:72–80. https://doi.org/10.1016/j.pec.2009.01.015 doi: 10.1016/j.pec.2009.01.015. [DOI] [PubMed]
  163. Ismail K, Thomas SM, Maissi E, Chalder T, Schmidt U, Bartlett J, et al. Motivational enhancement therapy with and without cognitive behavior therapy to treat type 1 diabetes: a randomized trial. Ann Intern Med 2008;149:708–19. https://doi.org/10.7326/0003-4819-149-10-200811180-00005 doi: 10.7326/0003-4819-149-10-200811180-00005. [DOI] [PubMed]
  164. Snoek FJ, van der Ven NC, Twisk JW, Hogenelst MH, Tromp-Wever AM, van der Ploeg HM, Heine RJ. Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled type 1 diabetic patients: long-term effects on HbA moderated by depression. A randomized controlled trial. Diabet Med 2008;25:1337–42. https://doi.org/10.1111/j.1464-5491.2008.02595.x doi: 10.1111/j.1464-5491.2008.02595.x. [DOI] [PubMed]
  165. Zoffmann V, Vistisen D, Due-Christensen M. Flexible guided self-determination intervention for younger adults with poorly controlled type 1 diabetes, decreased HbA1c and psychosocial distress in women but not in men: a real-life RCT. Diabet Med 2015;32:1239–46. https://doi.org/10.1111/dme.12698 doi: 10.1111/dme.12698. [DOI] [PubMed]
  166. Zoffmann V, Lauritzen T. Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial. Patient Educ Couns 2006;64:78–86. https://doi.org/10.1016/j.pec.2005.11.017 doi: 10.1016/j.pec.2005.11.017. [DOI] [PubMed]
  167. Graue M, Wentzel-Larsen T, Hanestad BR, Søvik O. Evaluation of a programme of group visits and computer-assisted consultations in the treatment of adolescents with Type 1 diabetes. Diabet Med 2005;22:1522–9. https://doi.org/10.1111/j.1464-5491.2005.01689.x doi: 10.1111/j.1464-5491.2005.01689.x. [DOI] [PubMed]
  168. Channon SJ, Huws-Thomas MV, Rollnick S, Hood K, Cannings-John RL, Rogers C, Gregory JW. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care 2007;30:1390–5. https://doi.org/10.2337/dc06-2260 doi: 10.2337/dc06-2260. [DOI] [PubMed]
  169. Ellis DA, Templin T, Naar-King S, Frey MA, Cunningham PB, Podolski CL, Cakan N. Multisystemic therapy for adolescents with poorly controlled type I diabetes: stability of treatment effects in a randomized controlled trial. J Consult Clin Psychol 2007;75:168–74. https://doi.org/10.1037/0022-006X.75.1.168 doi: 10.1037/0022-006X.75.1.168. [DOI] [PubMed]
  170. Nansel TR, Iannotti RJ, Simons-Morton BG, Cox C, Plotnick LP, Clark LM, Zeitzoff L. Diabetes personal trainer outcomes: short-term and 1-year outcomes of a diabetes personal trainer intervention among youth with type 1 diabetes. Diabetes Care 2007;30:2471–7. https://doi.org/10.2337/dc06-2621 doi: 10.2337/dc06-2621. [DOI] [PMC free article] [PubMed]
  171. Grey M, Whittemore R, Jaser S, Ambrosino J, Lindemann E, Liberti L, et al. Effects of coping skills training in school-age children with type 1 diabetes. Res Nurs Health 2009;32:405–18. https://doi.org/10.1002/nur.20336 doi: 10.1002/nur.20336. [DOI] [PMC free article] [PubMed]
  172. Wang YC, Stewart SM, Mackenzie M, Nakonezny PA, Edwards D, White PC. A randomized controlled trial comparing motivational interviewing in education to structured diabetes education in teens with type 1 diabetes. Diabetes Care 2010;33:1741–3. https://doi.org/10.2337/dc10-0019 doi: 10.2337/dc10-0019. [DOI] [PMC free article] [PubMed]
  173. Lehmkuhl HD, Storch EA, Cammarata C, Meyer K, Rahman O, Silverstein J, et al. Telehealth behavior therapy for the management of type 1 diabetes in adolescents. J Diabetes Sci Technol 2010;4:199–208. https://doi.org/10.1177/193229681000400125 doi: 10.1177/193229681000400125. [DOI] [PMC free article] [PubMed]
  174. Robling M, McNamara R, Bennert K, Butler CC, Channon S, Cohen D, et al. The effect of the Talking Diabetes consulting skills intervention on glycaemic control and quality of life in children with type 1 diabetes: cluster randomised controlled trial (DEPICTED study). BMJ 2012;344:e2359. https://doi.org/10.1136/bmj.e2359 doi: 10.1136/bmj.e2359. [DOI] [PMC free article] [PubMed]
  175. Sassmann H, de Hair M, Danne T, Lange K. Reducing stress and supporting positive relations in families of young children with type 1 diabetes: a randomized controlled study for evaluating the effects of the DELFIN parenting program. BMC Pediatr 2012;12:152. https://doi.org/10.1186/1471-2431-12-152 doi: 10.1186/1471-2431-12-152. [DOI] [PMC free article] [PubMed]
  176. Nansel TR, Iannotti RJ, Liu A. Clinic-integrated behavioral intervention for families of youth with type 1 diabetes: randomized clinical trial. Pediatrics 2012;129:e866–73. https://doi.org/10.1542/peds.2011-2858 doi: 10.1542/peds.2011-2858. [DOI] [PMC free article] [PubMed]
  177. Najmi SB, Marasi MR, Hashemipour M, Hovsepian S, Ghasemi M. The perceived self-efficacy and its interrelation with communication in family and glycemic control in adolescents with type 1 diabetes. Pak J Med Sci 2013;29:334–9. https://doi.org/10.12669/pjms.291(Suppl).3528 doi: 10.12669/pjms.291(Suppl).3528. [DOI]
  178. Husted GR, Thorsteinsson B, Esbensen BA, Gluud C, Winkel P, Hommel E, Zoffmann V. Effect of guided self-determination youth intervention integrated into outpatient visits versus treatment as usual on glycemic control and life skills: a randomized clinical trial in adolescents with type 1 diabetes. Trials 2014;15:321. https://doi.org/10.1186/1745-6215-15-321 doi: 10.1186/1745-6215-15-321. [DOI] [PMC free article] [PubMed]
  179. Jaser SS, Patel N, Rothman RL, Choi L, Whittemore R. Check it! A randomized pilot of a positive psychology intervention to improve adherence in adolescents with type 1 diabetes. Diabetes Educ 2014;40:659–67. https://doi.org/10.1177/0145721714535990 doi: 10.1177/0145721714535990. [DOI] [PMC free article] [PubMed]
  180. Katz ML, Volkening LK, Butler DA, Anderson BJ, Laffel LM. Family-based psychoeducation and Care Ambassador intervention to improve glycemic control in youth with type 1 diabetes: a randomized trial. Pediatr Diabetes 2014;15:142–50. https://doi.org/10.1111/pedi.12065 doi: 10.1111/pedi.12065. [DOI] [PMC free article] [PubMed]
  181. Christie D, Thompson R, Sawtell M, Allen E, Cairns J, Smith F, et al. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation – the CASCADE study. Health Technol Assess 2014;18(20). https://doi.org/10.3310/hta18200 doi: 10.3310/hta18200. [DOI] [PMC free article] [PubMed]
  182. Harris MA, Freeman KA, Duke DC. Seeing is believing: using Skype to improve diabetes outcomes in youth. Diabetes Care 2015;38:1427–34. https://doi.org/10.2337/dc14-2469 doi: 10.2337/dc14-2469. [DOI] [PubMed]
  183. Nansel TR, Laffel LM, Haynie DL, Mehta SN, Lipsky LM, Volkening LK, et al. Improving dietary quality in youth with type 1 diabetes: randomized clinical trial of a family-based behavioral intervention. Int J Behav Nutr Phys Act 2015;12:58. https://doi.org/10.1186/s12966-015-0214-4 doi: 10.1186/s12966-015-0214-4. [DOI] [PMC free article] [PubMed]
  184. Serlachius AS, Scratch SE, Northam EA, Frydenberg E, Lee KJ, Cameron FJ. A randomized controlled trial of cognitive behaviour therapy to improve glycaemic control and psychosocial wellbeing in adolescents with type 1 diabetes. J Health Psychol 2016;21:1157–69. https://doi.org/10.1177/1359105314547940 doi: 10.1177/1359105314547940. [DOI] [PubMed]
  185. Holmes CS, Chen R, Mackey E, Grey M, Streisand R. Randomized clinical trial of clinic-integrated, low-intensity treatment to prevent deterioration of disease care in adolescents with type 1 diabetes. Diabetes Care 2014;37:1535–43. https://doi.org/10.2337/dc13-1053 doi: 10.2337/dc13-1053. [DOI] [PMC free article] [PubMed]
  186. Wysocki T, Harris MA, Buckloh LM, Mertlich D, Lochrie AS, Taylor A, et al. Randomized, controlled trial of Behavioral Family Systems Therapy for Diabetes: maintenance and generalization of effects on parent-adolescent communication. Behav Ther 2008;39:33–46. https://doi.org/10.1016/j.beth.2007.04.001 doi: 10.1016/j.beth.2007.04.001. [DOI] [PubMed]
  187. Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, et al. The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression. Arch Gen Psychiatry 2004;61:1042–9. https://doi.org/10.1001/archpsyc.61.10.1042 doi: 10.1001/archpsyc.61.10.1042. [DOI] [PubMed]
  188. Karlsen B, Idsoe T, Dirdal I, Rokne Hanestad B, Bru E. Effects of a group-based counselling programme on diabetes-related stress, coping, psychological well-being and metabolic control in adults with type 1 or type 2 diabetes. Patient Educ Couns 2004;53:299–308. https://doi.org/10.1016/j.pec.2003.10.008 doi: 10.1016/j.pec.2003.10.008. [DOI] [PubMed]
  189. Wysocki T, Harris MA, Buckloh LM, Mertlich D, Lochrie AS, Taylor A, et al. Effects of behavioral family systems therapy for diabetes on adolescents’ family relationships, treatment adherence, and metabolic control. J Pediatr Psychol 2006;31:928–38. https://doi.org/10.1093/jpepsy/jsj098 doi: 10.1093/jpepsy/jsj098. [DOI] [PubMed]
  190. Heisler M, Vijan S, Makki F, Piette JD. Diabetes control with reciprocal peer support versus nurse care management: a randomized trial. Ann Intern Med 2010;153:507–15. https://doi.org/10.7326/0003-4819-153-8-201010190-00007 doi: 10.7326/0003-4819-153-8-201010190-00007. [DOI] [PMC free article] [PubMed]
  191. Rosenbek Minet LK, Wagner L, Lønvig EM, Hjelmborg J, Henriksen JE. The effect of motivational interviewing on glycaemic control and perceived competence of diabetes self-management in patients with type 1 and type 2 diabetes mellitus after attending a group education programme: a randomised controlled trial. Diabetologia 2011;54:1620–9. https://doi.org/10.1007/s00125-011-2120-x doi: 10.1007/s00125-011-2120-x. [DOI] [PubMed]
  192. Weinger K, Beverly EA, Lee Y, Sitnokov L, Ganda OP, Caballero AE. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial. Arch Intern Med 2011;171:1990–9. https://doi.org/10.1001/archinternmed.2011.502 doi: 10.1001/archinternmed.2011.502. [DOI] [PMC free article] [PubMed]
  193. Fischer HH, Eisert SL, Everhart RM, Durfee MJ, Moore SL, Soria S, et al. Nurse-run, telephone-based outreach to improve lipids in people with diabetes. Am J Manag Care 2012;18:77–84. [PubMed]
  194. Ellis DA, Naar-King S, Chen X, Moltz K, Cunningham PB, Idalski-Carcone A. Multisystemic therapy compared to telephone support for youth with poorly controlled diabetes: findings from a randomized controlled trial. Ann Behav Med 2012;44:207–15. https://doi.org/10.1007/s12160-012-9378-1 doi: 10.1007/s12160-012-9378-1. [DOI] [PMC free article] [PubMed]
  195. Lin EH, Von Korff M, Peterson D, Ludman EJ, Ciechanowski P, Katon W. Population targeting and durability of multimorbidity collaborative care management. Am J Manag Care 2014;20:887–95. [PMC free article] [PubMed]
  196. Safford MM, Andreae S, Cherrington AL, Martin MY, Halanych J, Lewis M, et al. Peer coaches to improve diabetes outcomes in rural Alabama: a cluster randomized trial. Ann Fam Med 2015;13(Suppl. 1):18–26. https://doi.org/10.1370/afm.1798 doi: 10.1370/afm.1798. [DOI] [PMC free article] [PubMed]
  197. Schroevers MJ, Tovote K, Keers JC, Links TP, Sanderman R, Fleer J. Individual mindfulness-based cognitive therapy for people with diabetes: a pilot randomized controlled trial. Mindfulness 2015;6:99–110. https://doi.org/10.1007/s12671-013-0235-5 doi: 10.1007/s12671-013-0235-5. [DOI]
  198. Feinglos MN, Hastedt P, Surwit RS. Effects of relaxation therapy on patients with type 1 diabetes mellitus. Diabetes Care 1987;10:72–5. https://doi.org/10.2337/diacare.10.1.72 doi: 10.2337/diacare.10.1.72. [DOI] [PubMed]
  199. Manning RM, Jung RT, Leese GP, Newton RW. The comparison of four weight reduction strategies aimed at overweight diabetic patients. Diabet Med 1995;12:409–15. https://doi.org/10.1111/j.1464-5491.1995.tb00504.x doi: 10.1111/j.1464-5491.1995.tb00504.x. [DOI] [PubMed]
  200. Spiess K, Sachs G, Pietschmann P, Prager R. A program to reduce onset distress in unselected type 1 diabetic patients: effects on psychological variables and metabolic control. Eur J Endocrinol 1995;132:580–6. https://doi.org/10.1530/eje.0.1320580 doi: 10.1530/eje.0.1320580. [DOI] [PubMed]
  201. Fosbury JA, Bosley CM, Ryle A, Sönksen PH, Judd SL. A trial of cognitive analytic therapy in poorly controlled type 1 patients. Diabetes Care 1997;20:959–64. https://doi.org/10.2337/diacare.20.6.959 doi: 10.2337/diacare.20.6.959. [DOI] [PubMed]
  202. Halford WK, Goodall TA, Nicholson JM. Diet and diabetes (II): a controlled trial of problem solving to improve dietary self-management in patients with insulin dependent diabetes. Psychol Health 1997;12:231–8. https://doi.org/10.1080/08870449708407401 doi: 10.1080/08870449708407401. [DOI]
  203. Didjurgeit U, Kruse J, Schmitz N, Stuckenschnieder P, Sawicki PT. A time-limited, problem-orientated psychotherapeutic intervention in type 1 diabetic patients with complications: a randomized controlled trial. Diabet Med 2002;19:814–21. https://doi.org/10.1046/j.1464-5491.2002.00811.x doi: 10.1046/j.1464-5491.2002.00811.x. [DOI] [PubMed]
  204. Weinger K, Schwartz E, Davis A, Rodriguez M, Simonson D, Jacobson A. Cognitive behavioral treatment in type 1 diabetes: a randomized controlled trial. Abstract from the American Diabetes Association 62nd Scientific Sessions, San Francisco, CA, USA, 2002. Diabetes 2002;51(Suppl. 2):A439.
  205. Stenström U, Göth A, Carlsson C, Andersson PO. Stress management training as related to glycaemic control and mood in adults with type 1 diabetes mellitus. Diabet Res Clin Pract 2003;60:147–52. https://doi.org/10.1016/S0168-8227(03)00018-4 doi: 10.1016/S0168-8227(03)00018-4. [DOI] [PubMed]
  206. van der Ven NC, Hogenelst MH, Tromp-Wever AM, Twisk JW, der Ploeg HM, Heine RJ, Snoek FJ. Short-term effects of cognitive behavioural group training (CBGT) in adult type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial. Diabet Med 2005;22:1619–23. https://doi.org/10.1111/j.1464-5491.2005.01691.x doi: 10.1111/j.1464-5491.2005.01691.x. [DOI] [PubMed]
  207. Anderson B, Wolf F, Burkhart M, Cornell R, Bacon G. Effects of peer-group intervention on metabolic control of adolescents with IDDM: randomized outpatient study. Diabetes Care 1989;12:179–83. https://doi.org/10.2337/diacare.12.3.179 doi: 10.2337/diacare.12.3.179. [DOI] [PubMed]
  208. Delameter A, Bubb J, Davis S, Smith J, Schmidt L, White N, et al. Randomized prospective study of self management training with newly diagnosed diabetic children. Diabetes Care 1990;13:492–8. https://doi.org/10.2337/diacare.13.5.492 doi: 10.2337/diacare.13.5.492. [DOI] [PubMed]
  209. Boardway R, Delamater A, Tomakowsky J, Gutai J. Stress management training for adolescents with diabetes. J Pediatr Psychol 1993;18:29–45. https://doi.org/10.1093/jpepsy/18.1.29 doi: 10.1093/jpepsy/18.1.29. [DOI] [PubMed]
  210. Mendez F, Olivares J, Ros C, Bermejo y MR. Aplicabilidad de estrategias reductoras del estres en los padres de ninos con diabetes mellitus insulinodependiente. Analisis y Modificacion de Conducta 1997;23:649–69.
  211. Grey M, Boland E, Davidson M, Yu C, Sullivan-Bolyai S, Tamborlane W. Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care 1998;21:902–8. https://doi.org/10.2337/diacare.21.6.902 doi: 10.2337/diacare.21.6.902. [DOI] [PubMed]
  212. Wysocki T, Greco P, Harris M, Bubb J, White N. Behavior therapy for families of adolescents with diabetes. Diabetes Care 2001;24:441–6. https://doi.org/10.2337/diacare.24.3.441 doi: 10.2337/diacare.24.3.441. [DOI] [PubMed]
  213. Wysocki T, Harris M, Wilkinson K, Sadler M, Mauras N, White N. Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes. Diabetes Care 2003;26:2043–7. https://doi.org/10.2337/diacare.26.7.2043 doi: 10.2337/diacare.26.7.2043. [DOI] [PubMed]
  214. Williams JW, Katon W, Lin EH, Nöel PH, Worchel J, Cornell J, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004;140:1015–24. https://doi.org/10.7326/0003-4819-140-12-200406150-00012 doi: 10.7326/0003-4819-140-12-200406150-00012. [DOI] [PubMed]
  215. Wing R, Epstein L, Nowalk M, Koeske R, Hagg S. Behavior change, weight loss, and physiological improvements in type II diabetic patients. J Consult Clin Psychol 1985;53:111–22. https://doi.org/10.1037/0022-006X.53.1.111 doi: 10.1037/0022-006X.53.1.111. [DOI] [PubMed]
  216. D’Eramo-Melkus G, Wylie-Rosett J, Hagan J. Metabolic impact of education in NIDDM. Diabetes Care 1992;15:864–9. https://doi.org/10.2337/diacare.15.7.864 doi: 10.2337/diacare.15.7.864. [DOI] [PubMed]
  217. Lane J, McCaskill C, Ross SL, Feinglos M, Surwit R. Relaxation training for NIDDM. Diabetes Care 1993;16:1087–94. https://doi.org/10.2337/diacare.16.8.1087 doi: 10.2337/diacare.16.8.1087. [DOI] [PubMed]
  218. Campbell L, Barth R, Gosper J, Jupp J, Simons L, Chisholm D. Impact of intensive educational approach to dietary change in NIDDM. Diabetes Care 1990;13:841–7. https://doi.org/10.2337/diacare.13.8.841 doi: 10.2337/diacare.13.8.841. [DOI] [PubMed]
  219. Aikens J, Kiolbasa T, Sobel R. Psychological predictors of glycemic change with relaxation training in non-insulin-dependent diabetes mellitus. Psychother Psychosom 1997;66:302–6. https://doi.org/10.1159/000289152 doi: 10.1159/000289152. [DOI] [PubMed]
  220. Henry J, Wilson P, Bruce D, Chisholm D, Rawling P. Cognitive-behavioural stress management for patients with non-insulin dependent diabetes mellitus. Psychology Health Med 1997;2:109–18. https://doi.org/10.1080/13548509708400569 doi: 10.1080/13548509708400569. [DOI]
  221. Ridgeway N, Harvill D, Harvill L, Falin T, Forester GM, Gose O. Improved control of Type 2 diabetes mellitus: a practical education/behavior modification program in a primary care clinic. South Med J 1999;92:667–72. https://doi.org/10.1097/00007611-199907000-00004 doi: 10.1097/00007611-199907000-00004. [DOI] [PubMed]
  222. Lustman P, Griffith L, Freedland K, Kissel S, Clouse R. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med 1998;129:613–21. https://doi.org/10.7326/0003-4819-129-8-199810150-00005 doi: 10.7326/0003-4819-129-8-199810150-00005. [DOI] [PubMed]
  223. Huang X, Song L, Li T. The effect of social support on type II diabetes with depression. Chin J Clin Psychol 2001;9:187–9.
  224. Kenardy J, Mensch M, Bowen K, Green B, Walton J. Group therapy for binge eating in type 2 diabetes: a randomized trial. Diabetes Med 2002;19:234–9. https://doi.org/10.1046/j.1464-5491.2002.00679.x doi: 10.1046/j.1464-5491.2002.00679.x. [DOI] [PubMed]
  225. Tsujiuchi T, Kumano H, Yoshiuchi K, He DG, Tsujiuchi Y, Kuboki T, et al.. The effect of Qi-Gong relaxation exercise on the control of type 2 diabetes mellitus. Diabetes Care 2002;25:241–2. https://doi.org/10.2337/diacare.25.1.241 doi: 10.2337/diacare.25.1.241. [DOI] [PubMed]
  226. Takii M, Uchigata Y, Komaki G, Nozaki T, Kawai H, Iwamoto Y, Kubo C. An integrated inpatient therapy for type 1 diabetic females with bulimia nervosa: a 3-year follow-up study. J Psychosom Res 2003;55:349–56. https://doi.org/10.1016/S0022-3999(02)00629-3 doi: 10.1016/S0022-3999(02)00629-3. [DOI] [PubMed]
  227. Attari A, Sartippour M, Amini M, Haghighi S. Effect of stress management training on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract 2006;73:23–8. https://doi.org/10.1016/j.diabres.2005.11.014 doi: 10.1016/j.diabres.2005.11.014. [DOI] [PubMed]
  228. Kubiak T, Hermanns N, Schreckling HJ, Kulzer B, Haak T. Evaluation of a self-management-based patient education program for the treatment and prevention of hypoglycemia-related problems in type 1 diabetes. Patient Educ Couns 2006;60:228–34. https://doi.org/10.1016/j.pec.2005.01.008 doi: 10.1016/j.pec.2005.01.008. [DOI] [PubMed]
  229. Ellis DA, Naar-King S, Frey M, Rowland M, Greger N. Case study: feasibility of multisystemic therapy as a treatment for urban adolescents with poorly controlled type 1 diabetes. J Pediatr Psychol 2003;28:287–93. https://doi.org/10.1093/jpepsy/jsg017 doi: 10.1093/jpepsy/jsg017. [DOI] [PubMed]
  230. García-Pérez L, Perestelo-Pérez L, Serrano-Aguilar P, Del Mar Trujillo-Martín M. Effectiveness of a psychoeducative intervention in a summer camp for children with type 1 diabetes mellitus. Diabetes Educ 2010;36:310–17. https://doi.org/10.1177/0145721710361784 doi: 10.1177/0145721710361784. [DOI] [PubMed]
  231. Bitsko MJ, Bean MK, Bart S, Foster RH, Thacker L, Francis GL. Psychological treatment improves hemoglobin A1c outcomes in adolescents with type 1 diabetes mellitus. J Clin Psychol Med Settings 2013;20:333–42. https://doi.org/10.1007/s10880-012-9350-z doi: 10.1007/s10880-012-9350-z. [DOI] [PubMed]
  232. Harris MA, Freeman KA, Beers M. Family therapy for adolescents with poorly controlled diabetes: initial test of clinical significance. J Pediatr Psychol 2009;34:1097–107. https://doi.org/10.1093/jpepsy/jsp009 doi: 10.1093/jpepsy/jsp009. [DOI] [PMC free article] [PubMed]
  233. Kim CJ, Hwang AR, Yoo JS. The impact of a stage-matched intervention to promote exercise behavior in participants with type 2 diabetes. Int J Nurs Stud 2004;41:833–41. https://doi.org/10.1016/j.ijnurstu.2004.03.009 doi: 10.1016/j.ijnurstu.2004.03.009. [DOI] [PubMed]
  234. Song MS, Kim HS. Effect of the diabetes outpatient intensive management programme on glycaemic control for type 2 diabetic patients. J Clin Nurs 2007;16:1367–73. https://doi.org/10.1111/j.1365-2702.2007.01800.x doi: 10.1111/j.1365-2702.2007.01800.x. [DOI] [PubMed]
  235. Forlani G, Lorusso C, Moscatiello S, Ridolfi V, Melchionda N, Di Domizio S, Marchesini G. Are behavioural approaches feasible and effective in the treatment of type 2 diabetes? A propensity score analysis vs. prescriptive diet. Nutr Metab Cardiovasc Dis 2009;19:313–20. https://doi.org/10.1016/j.numecd.2008.06.004 doi: 10.1016/j.numecd.2008.06.004. [DOI] [PubMed]
  236. Lee H, Kim MS, Park KY, Park HS, Kim IJ. Effects of a problem-solving counseling program to facilitate intensified walking on Koreans with type 2 diabetes. Jpn J Nurs Sci 2011;8:129–39. https://doi.org/10.1111/j.1742-7924.2010.00163.x doi: 10.1111/j.1742-7924.2010.00163.x. [DOI] [PubMed]
  237. Cervantes Cuesta MÁ, García-Talavera Espín NV, Brotons Román J, Núñez Sánchez MÁ, Brocal Ibáñez P, Villalba Martín P, et al. Psychoeducative groups help control type 2 diabetes in a primary care setting. Nutr Hosp 2013;28:497–505. https://doi.org/10.3305/nh.2013.28.2.6063 doi: 10.3305/nh.2013.28.2.6063. [DOI] [PubMed]
  238. Ounnapiruk L, Wirojratana V, Meehatchai N, Turale S. Effectiveness of a behavior modification program for older people with uncontrolled type 2 diabetes. Nurs Health Sci 2014;16:216–23. https://doi.org/10.1111/nhs.12089 doi: 10.1111/nhs.12089. [DOI] [PubMed]
  239. Bandura A. Self-Efficacy: The Exercise of Control. New York, NY: W.H. Freeman and Company; 1997.
  240. Wu SF, Liang SY, Lee MC, Yu NC, Kao MJ. The efficacy of a self-management programme for people with diabetes, after a special training programme for healthcare workers in Taiwan: a quasi-experimental design. J Clin Nurs 2014;23:2515–23. https://doi.org/10.1111/jocn.12440 doi: 10.1111/jocn.12440. [DOI] [PubMed]
  241. Kruger J, Brennan A, Thokala P, Basarir H, Jacques R, Elliott J, et al. The cost-effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model. Diabet Med 2013;30:1236–44. https://doi.org/10.1111/dme.12270 doi: 10.1111/dme.12270. [DOI] [PubMed]
  242. Heller S, Lawton J, Amiel S, Cooke D, Mansell P, Brennan A, et al. Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes. Programme Grants Appl Res 2014;2(5). https://doi.org/10.3310/pgfar02050 doi: 10.3310/pgfar02050. [DOI] [PubMed]
  243. Kruger J, Pollard D, Basarir H, Thokala P, Cooke D, Clark M, et al. Incorporating psychological predictors of treatment response into health economic simulation models: a case study in type 1 diabetes. Med Decis Making 2015;35:872–87. https://doi.org/10.1177/0272989X15590143 doi: 10.1177/0272989X15590143. [DOI] [PubMed]
  244. Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, et al. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial. BMJ Open 2018;8:e016766. https://doi.org/10.1136/bmjopen-2017-016766 doi: 10.1136/bmjopen-2017-016766. [DOI] [PMC free article] [PubMed]
  245. Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, et al. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Health Technol Assess 2017;21(20). https://doi.org/10.3310/hta21200 doi: 10.3310/hta21200. [DOI] [PMC free article] [PubMed]
  246. Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, et al. Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model. Diabet Med 2014;31:477–86. https://doi.org/10.1111/dme.12371 doi: 10.1111/dme.12371. [DOI] [PubMed]
  247. Alva M, Gray A, Mihaylova B, Clarke P. The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity. Health Econ 2014;23:487–500. https://doi.org/10.1002/hec.2930 doi: 10.1002/hec.2930. [DOI] [PubMed]
  248. Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002;22:340–9. https://doi.org/10.1177/0272989X0202200412 doi: 10.1177/0272989X0202200412. [DOI] [PubMed]
  249. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002;25:2238–43. https://doi.org/10.2337/diacare.25.12.2238 doi: 10.2337/diacare.25.12.2238. [DOI] [PubMed]
  250. Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H, Kruger J. The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type 1 diabetes. Med Decis Making 2016;36:1020–33. https://doi.org/10.1177/0272989X16658660 doi: 10.1177/0272989X16658660. [DOI] [PMC free article] [PubMed]
  251. Ridge K, Bartlett J, Cheah Y, Thomas S, Lawrence-Smith G, Winkley K, Ismail K. Do the effects of psychological treatments on improving glycemic control in type 1 diabetes persist over time? A long-term follow-up of a randomized controlled trial. Psychosom Med 2012;74:319–23. https://doi.org/10.1097/PSY.0b013e31824c181b doi: 10.1097/PSY.0b013e31824c181b. [DOI] [PubMed]
  252. Ismail K, Maissi E, Thomas S, Chalder T, Schmidt U, Bartlett J, et al. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess 2010;14(22). https://doi.org/10.3310/hta14220 doi: 10.3310/hta14220. [DOI] [PubMed]
  253. Curtis L, Burns A. Unit Costs of Health and Social Care 2013. Canterbury: Personal Social Services Research Unit, University of Kent; 2013.
  254. Strong M, Oakley JE, Brennan A. Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach. Med Decis Making 2014;34:311–26. https://doi.org/10.1177/0272989X13505910 doi: 10.1177/0272989X13505910. [DOI] [PMC free article] [PubMed]
  255. Juvenile Diabetes Research Foundation (JDFR). Type 1 Diabetes Facts and Figures. London: JDRF; 2018. URL: https://jdrf.org.uk/information-support/about-type-1-diabetes/facts-and-figures/?gclid=EAIaIQobChMIk-zrw8Pr2QIVsxbTCh344QCzEAAYASAAEgK9C_D_BwE.%202018 (accessed 14 March 2018).
  256. Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle PJ, et al. The impact of type 2 diabetes prevention programmes based on risk-identification and lifestyle intervention intensity strategies: a cost-effectiveness analysis. 2017;34:632–40. doi: 10.1111/dme.13314. [DOI] [PubMed]
  257. UK Data Service. Health Survey for England. Colchester: UK Data Service; 2012. URL: https://discover.ukdataservice.ac.uk/series/?sn=2000021 (accessed March 2018).
  258. Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, et al. A statistical model to describe longitudinal and correlated metabolic risk factors: the Whitehall II prospective study. J Public Health 2016;38:679–87. https://doi.org/10.1093/pubmed/fdv160 doi: 10.1093/pubmed/fdv160. [DOI] [PMC free article] [PubMed]
  259. Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol 2005;34:251–6. https://doi.org/10.1093/ije/dyh372 doi: 10.1093/ije/dyh372. [DOI] [PubMed]
  260. Bennett H, McEwan P, Bergenheim K, Gordon J. Assessment of unmet clinical need in type 2 diabetic patients on conventional therapy in the UK. Diabetes Ther 2014;5:567–78. https://doi.org/10.1007/s13300-014-0079-6 doi: 10.1007/s13300-014-0079-6. [DOI] [PMC free article] [PubMed]
  261. Clarke PM, Gray AM, Briggs A, Farmer AJ, Fenn P, Stevens RJ, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004;47:1747–59. https://doi.org/10.1007/s00125-004-1527-z doi: 10.1007/s00125-004-1527-z. [DOI] [PubMed]
  262. Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM. UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia 2013;56:1925–33. https://doi.org/10.1007/s00125-013-2940-y doi: 10.1007/s00125-013-2940-y. [DOI] [PubMed]
  263. Office for National Statistics. Mortality Statistics: Deaths Registered in England and Wales. 2013. URL: www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredinenglandandwalesseriesdr/2014-10-29 (accessed 1 December 2017).
  264. Curtis L, Burns A. Unit Costs of Health and Social Care 2017. Canterbury: Personal Social Services Research Unit, University of Kent; 2017.
  265. Joint Formulary Committee. British National Formulary (online). London: BMJ Group and Pharmaceutical Press. URL: www.medicinescomplete.com (accessed 12 March 2018).
  266. Curtis L. Unit Costs of Health and Social Care 2014. Canterbury: Personal Social Services Research Unit, University of Kent; 2014. URL: www.pssru.ac.uk/project-pages/unit-costs/2014/ (accessed 14 March 2018).
  267. National Institute for Health and Care Excellence (NICE). Appendix F: Full Health Economics Report. London: NICE; 2015. URL: www.nice.org.uk/guidance/ng28/evidence/appendix-f-full-health-economics-report-pdf-2185320355 (accessed 14 March 2018).
  268. Kearns B, Rafia R, Leaviss J, Preston L, Brazier JE, Palmer S, Ara R. The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Serv Res 2017;17:78. https://doi.org/10.1186/s12913-017-2003-z doi: 10.1186/s12913-017-2003-z. [DOI] [PMC free article] [PubMed]
  269. Public Health England. 3.8 Million People in England Now Have Diabetes. London: Public Health England; 2016. URL: www.gov.uk/government/news/38-million-people-in-england-now-have-diabetes (accessed 14 March 2018).
  270. Grimm SE, Strong M, Brennan A, Wailoo AJ. The HTA Risk Analysis Chart: visualising the need for and potential value of managed entry agreements in health technology assessment. PharmacoEconomics 2017;35:1287–96. https://doi.org/10.1007/s40273-017-0562-9 doi: 10.1007/s40273-017-0562-9. [DOI] [PMC free article] [PubMed]
  271. Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods 2010;1:112–25. https://doi.org/10.1002/jrsm.11 doi: 10.1002/jrsm.11. [DOI] [PubMed]
  272. Group DS. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002;325:746. https://doi.org/10.1136/bmj.325.7367.746 doi: 10.1136/bmj.325.7367.746. [DOI] [PMC free article] [PubMed]
  273. Cox DJ, Gonder-Frederick L, Julian D, Cryer P, Lee JH, Richards FE, Clarke W. Intensive versus standard blood glucose awareness training (BGAT) with insulin-dependent diabetes: mechanisms and ancillary effects. Psychosom Med 1991;53:453–62. https://doi.org/10.1097/00006842-199107000-00010 doi: 10.1097/00006842-199107000-00010. [DOI] [PubMed]
  274. Uchendu C, Blake H. Effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 2017;34:328–39. https://doi.org/10.1111/dme.13195 doi: 10.1111/dme.13195. [DOI] [PubMed]
  275. van der Feltz-Cornelis CM, Nuyen J, Stoop C, Chan J, Jacobson AM, Katon W, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 2010;32:380–95. https://doi.org/10.1016/j.genhosppsych.2010.03.011 doi: 10.1016/j.genhosppsych.2010.03.011. [DOI] [PubMed]
  276. Channon S, Smith VJ, Gregory JW. A pilot study of motivational interviewing in adolescents with diabetes. Arch Dis Child 2003;88:680–3. https://doi.org/10.1136/adc.88.8.680 doi: 10.1136/adc.88.8.680. [DOI] [PMC free article] [PubMed]
  277. Delamater AM, de Wit M, McDarby V, Malik J, Acerini CL, International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes 2014;15(Suppl. 20):232–44. https://doi.org/10.1111/pedi.12191 doi: 10.1111/pedi.12191. [DOI] [PubMed]
  278. Thunander M, Petersson C, Jonzon K, Fornander J, Ossiansson B, Torn C, et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 2008;82:247–55. https://doi.org/10.1016/j.diabres.2008.07.022 doi: 10.1016/j.diabres.2008.07.022. [DOI] [PubMed]
  279. Due-Christensen M, Zoffmann V, Willaing I, Hopkins D, Forbes A. The process of adaptation following a new diagnosis of type 1 diabetes in adulthood: a meta-synthesis. Qual Health Res 2018;28:245–58. https://doi.org/10.1177/1049732317745100 doi: 10.1177/1049732317745100. [DOI] [PubMed]
  280. Hind D, O’Cathain A, Cooper CL, Parry GD, Isaac CL, Rose A, et al. The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: a qualitative study of people with multiple sclerosis. Psychol Health 2010;25:699–712. https://doi.org/10.1080/08870440902842739 doi: 10.1080/08870440902842739. [DOI] [PubMed]
  281. Moss-Morris R. Adjusting to chronic illness: time for a unified theory. Br J Health Psychol 2013;18:681–6. https://doi.org/10.1111/bjhp.12072 doi: 10.1111/bjhp.12072. [DOI] [PubMed]
  282. Charalampopoulos D, Hesketh KR, Amin R, Paes VM, Viner RM, Stephenson T. Psycho-educational interventions for children and young people with type 1 diabetes in the UK: how effective are they? A systematic review and meta-analysis. PLOS ONE 2017;12:e0179685. https://doi.org/10.1371/journal.pone.0179685 doi: 10.1371/journal.pone.0179685. [DOI] [PMC free article] [PubMed]
  283. Abualula NA, Jacobsen KH, Milligan RA, Rodan MF, Conn VS. Evaluating diabetes educational interventions with a skill development component in adolescents with type 1 diabetes: a systematic review focusing on quality of life. Diabetes Educ 2016;42:515–28. https://doi.org/10.1177/0145721716658356 doi: 10.1177/0145721716658356. [DOI] [PubMed]
  284. Northam EA, Matthews LK, Anderson PJ, Cameron FJ, Werther GA. Psychiatric morbidity and health outcome in type 1 diabetes – perspectives from a prospective longitudinal study. Diabet Med 2005;22:152–7. https://doi.org/10.1111/j.1464-5491.2004.01370.x doi: 10.1111/j.1464-5491.2004.01370.x. [DOI] [PubMed]
  285. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141–5. https://doi.org/10.1056/NEJM198707163170304 doi: 10.1056/NEJM198707163170304. [DOI] [PubMed]
  286. Pillay J, Armstrong MJ, Butalia S, Donovan LE, Sigal RJ, Vandermeer B, et al. Behavioral programs for type 2 diabetes mellitus: a systematic review and network meta-analysis. Ann Intern Med 2015;163:848–60. https://doi.org/10.7326/M15-1400 doi: 10.7326/M15-1400. [DOI] [PubMed]
  287. Xie J, Deng W. Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat 2017;13:2681–90. https://doi.org/10.2147/NDT.S116465 doi: 10.2147/NDT.S116465. [DOI] [PMC free article] [PubMed]
  288. Alam R, Sturt J, Lall R, Winkley K. An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and generalist clinicians on glycaemic control and on psychological status. Patient Educ Couns 2009;75:25–36. https://doi.org/10.1016/j.pec.2008.08.026 doi: 10.1016/j.pec.2008.08.026. [DOI] [PubMed]
  289. Graves H, Garrett C, Amiel SA, Ismail K, Winkley K. Psychological skills training to support diabetes self-management: qualitative assessment of nurses’ experiences. Prim Care Diabetes 2016;10:376–82. https://doi.org/10.1016/j.pcd.2016.03.001 doi: 10.1016/j.pcd.2016.03.001. [DOI] [PubMed]
  290. Gillam SJ, Siriwardena AN, Steel N. Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review. Ann Fam Med 2012;10:461–8. https://doi.org/10.1370/afm.1377 doi: 10.1370/afm.1377. [DOI] [PMC free article] [PubMed]
  291. Diabetes UK. The Future of Diabetes. London: Diabetes UK; 2017. URL: www.diabetes.org.uk/resources-s3/2017-11/1111B%20The%20future%20of%20diabetes%20report_FINAL_.pdf (accessed 14 March 2018).
  292. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Med 2009;6:e1000100. https://doi.org/10.1371/journal.pmed.1000100 doi: 10.1371/journal.pmed.1000100. [DOI] [PMC free article] [PubMed]
  293. NHS England. Adult Improving Access to Psychological Therapies Programme. London: NHS England; 2017. URL: www.england.nhs.uk/mental-health/adults/iapt/ (accessed 14 March 2018).
  294. Byrne M, O’Connell A, Egan AM, Dinneen SF, Hynes L, O’Hara MC, et al. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study. Trials 2017;18:602. https://doi.org/10.1186/s13063-017-2364-y doi: 10.1186/s13063-017-2364-y. [DOI] [PMC free article] [PubMed]
  295. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002;21:1559–73. https://doi.org/10.1002/sim.1187 doi: 10.1002/sim.1187. [DOI] [PubMed]
  296. Diabetes UK. Minding the Gap. London: Diabetes UK; 2008. URL: www.diabetes.org.uk/resources-s3/2017-11/minding_the_gap_psychological_report.pdf (accessed 14 March 2018).
  297. Diabetes UK. Paediatric Best Practice Tariff. London: Diabetes UK; 2013. URL: www.diabetes.org.uk/resources-s3/2017-09/Paediatric%20Diabetes%20Best%20Practice%20Tariff%20Criteria.pdf (accessed 14 March 2018).
  298. Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013;66:719–25. https://doi.org/10.1016/j.jclinepi.2012.03.013 doi: 10.1016/j.jclinepi.2012.03.013. [DOI] [PubMed]
  299. Bonell CP, Hargreaves JR, Cousens SN, Ross DA, Hayes R, Petticrew M, Kirkwood BR. Alternatives to randomisation in the evaluation of public health interventions: design challenges and solutions. J Epidemiol Community Health 2011;65:582–7. https://doi.org/10.1136/jech.2008.082602 doi: 10.1136/jech.2008.082602. [DOI] [PubMed]
  300. Ismail K, Winkley K, de Zoysa N, Patel A, Heslin M, Graves H, et al. Nurse-led psychological intervention for type 2 diabetes: a cluster randomised controlled trial (Diabetes-6 study) in primary care. Br J Gen Pract 2018;68:e531–40. https://doi.org/10.3399/bjgp18X696185 doi: 10.3399/bjgp18X696185. [DOI] [PMC free article] [PubMed]
  301. Dhatariya KK, Skedgel C, Fordham R. The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use. Diabet Med 2017;34:1361–6. https://doi.org/10.1016/j.jval.2017.08.573 doi: 10.1016/j.jval.2017.08.573. [DOI] [PubMed]
  302. McEwan P, Poole CD, Tetlow T, Holmes P, Currie CJ. Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK. Curr Med Res Opin 2007;23(Suppl. 1):S7–19. https://doi.org/10.1185/030079907X167561 doi: 10.1185/030079907X167561. [DOI]
  303. Department of Health and Social Care. NHS Reference Costs: Financial Year 2011 to 2012. URL: www.gov.uk/government/publications/nhs-reference-costs-financial-year-2011-to-2012 (accessed 7 November 2019).
  304. Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, et al. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabet Med 2007;24:187–94. doi: 10.1111/j.1464-5491.2006.02057.x. [DOI] [PubMed]
  305. National Institute for Health and Care Excellence. Ranibizumab for Treating Diabetic Macular Oedema. Technology appraisal guidance [TA274]. 2013. URL: www.nice.org.uk/guidance/ta274 (accessed 26 Janurary 2018).
  306. Alva ML, Gray A, Mihaylova B, Leal J, Holman RR The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabet Med 2015;32:459–66. https://10.1111/dme.12647 doi: 10.1111/dme.12647. [DOI] [PubMed]
  307. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjønneland A, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920–31. https://doi.org/10.1093/jnci/djj246 doi: 10.1093/jnci/djj246. [DOI] [PubMed]
  308. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004;111:762–71. https://doi.org/10.1002/ijc.20315 doi: 10.1002/ijc.20315. [DOI] [PubMed]
  309. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78. https://doi.org/10.1016/S0140-6736(08)60269-X doi: 10.1016/S0140-6736(08)60269-X. [DOI] [PubMed]
  310. Schett G, Kleyer A, Perricone C, Sahinbegovic E, Iagnocco A, Zwerina J, et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care 2013;36:403–9. https://doi.org/10.2337/dc12-0924 doi: 10.2337/dc12-0924. [DOI] [PMC free article] [PubMed]
  311. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008;299:2751–9. https://doi.org/10.1001/jama.299.23.2751 doi: 10.1001/jama.299.23.2751. [DOI] [PMC free article] [PubMed]
  312. Whyte EM, Mulsant BH, Vanderbilt J, Dodge HH, Ganguli M. Depression after stroke: a prospective epidemiological study. J Am Geriatr Soc 2004;52:774–8. https://doi.org/10.1111/j.1532-5415.2004.52217.x doi: 10.1111/j.1532-5415.2004.52217.x. [DOI] [PubMed]
  313. Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007;11(14). https://doi.org/10.3310/hta11140 doi: 10.3310/hta11140. [DOI] [PubMed]
  314. Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst 2004;96:1322–30. https://doi.org/10.1093/jnci/djh255 doi: 10.1093/jnci/djh255. [DOI] [PubMed]
  315. Black C, Clar C, Henderson R, MacEachern C, McNamee P, Quayyum Z, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. Health Technol Assess 2009;13(52). https://doi.org/10.3310/hta13520 doi: 10.3310/hta13520. [DOI] [PubMed]
  316. Benedict A, Arellano J, De Cock E, Baird J. Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland. J Affect Disord 2010;120:94–104. https://doi.org/10.1016/j.jad.2009.04.017 doi: 10.1016/j.jad.2009.04.017. [DOI] [PubMed]
  317. Poole CD, Tetlow T, McEwan P, Holmes P, Currie CJ. The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis. Curr Med Res Opin 2007;23:S41–S8. https://doi.org/10.1185/030079907X167589 doi: 10.1185/030079907X167589. [DOI]
  318. Curtis L. Unit Costs of Health and Social Care 2012. Canterbury: Personal Social Services Research Unit, University of Kent; 2012.
  319. Burr JM, Mowatt G, Hernández R, Siddiqui MA, Cook J, Lourenco T, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess 2007;11(41). https://doi.org/10.3310/hta11410 doi: 10.3310/hta11410. [DOI] [PubMed]
  320. Department of Health and Social Care (DHSC). NHS Reference Costs 2012 to 2013. London: DHSC; 2015. URL: www.gov.uk/government/publications/nhs-reference-costs-2012-to-2013 (accessed 14 March 2018).
  321. Ara R, Pandor A, Stevens J, Rees A, Rafia R. Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation. Health Technol Assess 2009;13(34). https://doi.org/10.3310/hta13340 doi: 10.3310/hta13340. [DOI] [PubMed]
  322. Palmer S, Sculpher M, Philips Z, Robinson M, Ginnelly L, Bakhai A, et al. A cost-effectiveness model comparing alternative management strategies for the use of glycoprotein IIb/IIIa antagonists in non-ST-elevation acute coronary syndrome. London: National Institute for Health and Care Excellence; 2002. URL: www.nice.org.uk/guidance/ta47/documents/costeffectiveness-model-glycoprotein-antagonists-2 (accessed 1 December 2017).
  323. Youman P, Wilson K, Harraf F, Kalra L. The economic burden of stroke in the United Kingdom. PharmacoEconomics 2003;21(Suppl. 1):43–50. https://doi.org/10.2165/00019053-200321001-00005 doi: 10.2165/00019053-200321001-00005. [DOI] [PubMed]
  324. Luengo-Fernandez R, Gray AM, Rothwell PM, Oxford Vascular Study. A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke. Stroke 2012;43:3343–51. https://doi.org/10.1161/STROKEAHA.112.667204 doi: 10.1161/STROKEAHA.112.667204. [DOI] [PMC free article] [PubMed]
  325. Baboolal K, McEwan P, Sondhi S, Spiewanowski P, Wechowski J, Wilson K. The cost of renal dialysis in a UK setting – a multicentre study. Nephrol Dial Transplant 2008;23:1982–9. https://doi.org/10.1093/ndt/gfm870 doi: 10.1093/ndt/gfm870. [DOI] [PubMed]
  326. Organ Donation. Cost-effectiveness of Transplantation. NHS Blood and Transplant. 2013. URL: www.organdonation.nhs.uk/newsroom/fact_sheets/organ_donation_registry_fact_sheet_7_21337.pdf (accessed 14 March 2018).
  327. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 2003;26:1790–5. https://doi.org/10.2337/diacare.26.6.1790 doi: 10.2337/diacare.26.6.1790. [DOI] [PubMed]
  328. Madan J, Rawdin A, Stevenson M, Tappenden P. A rapid-response economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach. Value Health 2010;13:215–21. https://doi.org/10.1111/j.1524-4733.2009.00667.x doi: 10.1111/j.1524-4733.2009.00667.x. [DOI] [PubMed]
  329. Tappenden P, Eggington S, Nixon R, Chilcott J, Sakai H, Karnon J. Colorectal Cancer Screening Options Appraisal. Report to the English Bowel Cancer Screening Working Group. Sheffield: University of Sheffield; 2004.
  330. Oxford Economics. The Economic Costs of Arthritis for the UK Economy. Oxford: Oxford Economics; 2014. URL: www.oxfordeconomics.com/publication/open/222531 (accessed 14 March 2018).
  331. Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Searle A, Haase AM, et al. A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trial. Health Technol Assess 2012;16(10). https://doi.org/10.3310/hta16100 doi: 10.3310/hta16100. [DOI] [PubMed]
  332. National Institute for Health and Care Excellence (NICE). CG127 Hypertension in Adults: Diagnosis and Management. London: NICE; 2011. URL: http://guidance.nice.org.uk/CG127/CostingTemplate/xls/English (accessed 14 March 2018).
  333. Curtis L, Burns A. Unit Costs of Health and Social Care 2016. Canterbury: Personal Social Services Research Unit, University of Kent; 2016.
  334. DAFNE. Fact Sheet Six. URL: www.dafne.uk.com/uploads/135/documents/06_factsheetsix_12pt_18_06_12.pdf (accessed 17 October 2019).
  335. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. London: NICE; 2013. [PubMed]
  336. Walker C. Effects of Motivational Interviewing on Diabetes Self-management Behavoiurs and Glycemic Control in Type 2 Diabetes: A Translational Study. PhD thesis. Cincinnati, OH: University of Cincinnati; 2012.
  337. Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, et al. Delivering the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ 2010;341:c4093. https://10.1136/bmj.c4093 doi: 10.1136/bmj.c4093. [DOI] [PMC free article] [PubMed]

RESOURCES